CD81 and ovarian carcinoma: To determine whether ROS influence the TME through tumor exosomal miRNAs, we treated ovarian cancer A2780 cells with or without H2O2, and purified A2780-derived exosomes characterized by positive exosomal markers CD63 and CD81, and a negative exosomal marker calnexin (Fig. 1A).